Apparatus for delivering fluid to treat renal hypertension

Information

  • Patent Grant
  • 11185663
  • Patent Number
    11,185,663
  • Date Filed
    Friday, November 3, 2017
    7 years ago
  • Date Issued
    Tuesday, November 30, 2021
    3 years ago
Abstract
A surgical apparatus for delivering fluid to treat renal hypertension including an elongated member having a distal tip and a plurality of openings formed in a sidewall proximal of the distal tip. A plurality of fluid delivery members are movably positioned in the elongated member, each of the fluid delivery members having a lumen and at least one opening communicating with the lumen for delivering fluid extravascularly. An actuator is operatively associated with the fluid delivery members, the actuator actuable to a first position to move the fluid delivery members from a retracted position within the elongated member to a deployed position extending radially with respect to the elongated member. A balloon is expandable radially from the elongated member to seal the renal artery during application of fluid through the fluid delivery members.
Description
BACKGROUND
Technical Field

This application relates to a surgical apparatus for delivering fluid and more particularly to an apparatus that delivers fluid to treat renal hypertension.


Background of Related Art

Renal hypertension consists of high blood pressure caused by the kidneys hormonal response to narrowing of the arteries supplying the kidneys. That is, when there is low blood flow, the kidneys respond by increasing blood pressure as the kidneys give off hormones that signal the body to retain salt and water, thereby causing a rise in blood pressure. Narrowing of the arteries is referred to as renal artery stenosis and can be caused by arterosclerosis or arterial injury. Hypertension can also be caused by hyperactive renal sympathetic nerves.


There are various treatments for renal hypertension. One treatment mode is the use of anti-hypertension drugs to modulate blood pressure. There are also surgical treatments. One surgical treatment is angioplasty, which can be accompanied by stent placement. However, restenosis often occurs. Other treatments include application of radiofrequency ablation to destroy the nerves within the renal artery with the objective of reducing blood pressure.


U.S. Pat. Nos. 8,339,443 and 8,465,752 disclose catheters advanced intravascularly. A needle is advanced through the blood vessel wall into adventitial tissue within a perivascular region. A neuromodulating agent is injected into the perivascular region to enhance concentrations of the agent in tissue surrounding the blood vessel, e.g., the renal artery, to apply directly to the area where nerve cells can be affected. By affecting, e.g., severing, the nerves, blood pressure can be reduced.


The need exists for an improved device for treating renal hypertension.


SUMMARY

The present invention advantageously provides a surgical apparatus for delivering fluid outside the vessel to treat renal hypertension. In accordance with one aspect of the present invention, an apparatus is provided comprising an elongated member having a distal tip and a plurality of openings formed in a sidewall proximal of the distal tip, a plurality of fluid delivery members movably positioned in the elongated member and having a lumen and at least one opening communicating with the lumen for delivering fluid extravascularly, and an actuator operatively associated with the fluid delivery members. The actuator is actuable to a first position to move the plurality of fluid delivery members from a retracted position within the elongated member to a deployed position extending radially with respect to the elongated member. A balloon is expandable to seal off the renal artery during fluid injection.


In some embodiments, the fluid delivery members exit the apparatus proximally of the balloon; in other embodiments, the fluid delivery members exit the apparatus distally of the balloon.


Preferably the distal tips of the fluid delivery members are sharp to penetrate a wall of the artery. The actuator is preferably axially slidable to move the fluid delivery members between the retracted and deployed position. In some embodiments, the distal tips of the fluid delivery members do not extend distally of the distal tip of the elongated member. The fluid delivery members can be composed of shape memory metal, or alternately, of stainless steel, or of other materials.


A retention member can be provided in the form of a tab mounted on the actuator that engages one of the recesses formed in a housing through which the actuator is slidably received. A visible indicator may be provided to indicate the position of the plurality of fluid delivery members.


In accordance with another aspect of the present invention, a method for treating renal hypertension is provided comprising:


inserting an apparatus intravascularly to a renal artery;


inflating a balloon on the apparatus to seal off the renal artery;


advancing an actuator in a first direction to deploy a plurality of tines radially through side openings in the apparatus so the tines penetrate a wall of the artery; and


injecting fluid through a lumen in the tines and through side openings in the tines to apply ablation fluid outside the vessel wall.


In one embodiment, the plurality of tines are composed of shape memory material.


In some embodiments, a distal tip of the tines does not extend distally of a distal tip of the apparatus. In some embodiments, the tines exit the apparatus proximally of the balloon; in other embodiments, the tines exit the apparatus distally of the balloon.





BRIEF DESCRIPTION OF THE DRAWINGS

Preferred embodiment(s) of the present disclosure are described herein with reference to the drawings wherein:



FIG. 1 is a perspective view of the surgical apparatus of the present invention, the fluid delivery members (tines) shown in the retracted position within the catheter;



FIG. 2 is an exploded view of the catheter of FIG. 1;



FIG. 3 is a longitudinal cross-sectional view taken along line 3-3 of FIG. 1;



FIG. 4 is a longitudinal cross-sectional view taken along line 4-4 of FIG. 1;



FIG. 5 is a transverse cross-sectional view taken along line 5-5 of FIG. 3;



FIGS. 6-8 illustrate the insertion method for the apparatus of FIG. 1 to treat renal hypertension wherein FIG. 6 illustrates insertion of a guidewire through the femoral artery, FIG. 7 illustrates insertion of the apparatus of FIG. 1 over the guidewire and FIG. 8 illustrates inflation of the balloon to close off the renal artery;



FIG. 8A is a view similar to FIG. 8 except showing an alternate embodiment of the apparatus having centering wires;



FIG. 8B is a close up view of the circled area of FIG. 8A;



FIG. 9 is a perspective view of the balloon/tine region of the apparatus of FIG. 1 showing the tines exiting distally of the balloon; and



FIG. 10 is a perspective view of the balloon/tine region of an alternate embodiment of the apparatus of the present invention showing the tines exiting proximally of the balloon.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

Referring now in detail to the drawings where like reference numerals identify similar or like components throughout the several views, the apparatus of the present invention for delivering fluid for treatment of renal hypertension is designated generally by reference numeral 10 and illustrated in FIGS. 1 and 2. Apparatus 10 includes a flexible catheter or outer member (tube) 12, an actuator or plunger 30 extending proximally from housing 13, a plurality of fluid delivery members 40 and an expandable balloon 50. The fluid delivery members (tines) 40 are movable with respect to the outer member (tube) 12 in response to movement of the plunger 30 as the delivery members 40 are operably connected to plunger 30. The tines 40 include a lumen 44 in fluid communication with one or more side openings 41 for delivery of fluid to the target tissue and extend through respective side windows 16 in the outer member 12 (FIG. 3). In addition or as an alternative, the tines 40 can terminate in a distal opening to deliver fluid.


The tines 40 in one embodiment extend in their advanced position to a position proximal of the distal tip of the outer tube 12, thereby controlling the zone of fluid delivery. Since the tines in FIG. 1 are in the retracted position within the outer member 12, they are not visible in this Figure. The longitudinal cross-sectional view of FIG. 3 shows the tines 40 in their retracted position. The tines terminate in penetrating tips 42 to penetrate the vessel wall.


The housing 13 at the proximal end of the outer member 12 can be formed by two housing halves attached together. Wings 17 with finger recesses 18 facilitate gripping by the clinician.


A fluid port (not shown) can be provided to communicate with lumen 23 in catheter 12 to provide inflation fluid to inflate the balloon 50.


Plunger (actuator) 30 can optionally include finger ring 32 and is movable with respect to the housing from a retracted (proximal) position (FIG. 1) to an advanced (distal) position to deploy the tines 40 from the outer tube 12. An indicator (not shown) can be provided for visualization through a window on the housing 13 to indicate the position of the plunger 30 which in turn indicates the position of the tines 40 with respect to the elongated member 12.


Plunger 30 is shown in the initial position in FIGS. 1-3 which corresponds to the proximal most position of the tines 40 in which they are retracted within outer tube 12 and their penetrating tips 42 are not exposed. The tines 40 can be connected at their proximal ends to a distal end of a connecting tube (described below) which is attached at its proximal end to a distal end of plunger 30 to effect movement of the tines 40. Alternatively, a proximal end of the tines 40 can be attached to a distal end of the plunger 30 and the connecting tube described below positioned within the plunger 30.


Catheter 12 has three longitudinally extending lumens 20, 22, 24 (see FIG. 5) configured and dimensioned to enable sliding movement of the tines 40 between retracted and advanced (extended) positions. Central lumen 29 is configured to receive a guidewire for over the wire insertion of the catheter 12.


Catheter 12 in one embodiment is mounted to housing 13 by pin 19 extending into receiving groove 15, although other attachments are contemplated. The attachment can be done during manufacture or alternatively done by the clinician after the apparatus packaging is opened.


An inner connecting tube is provided within housing 13, communicating with fluid source tube 25 having a lumen formed therein to accommodate fluid flow. Attachment tube 28 extends distally from housing 13 and is coupled to a proximal region of the outer tube 12. Inner connecting tube provides fluid to the tines 40 from source tube 25 to provide fluid communication between the lumen of connecting tube and the lumen of each tine 40.


The inner connecting tube can be composed of metal and have a flattened (swaged) region to help prevent rotation of the inner tube. The tines (fluid delivery members) 40 can be attached to the distal end of the inner tube, preferably by crimping or potting, so that axial movement of the inner tube moves the tines axially. Glue or solder may further be used at the attachment to seal the connection to the tines 40 to prevent fluid leakage. The inner tube is in fluid communication with the lumens in the tines 40 to deliver fluid received from the source tube 25.


Turning now to the tines (fluid delivery members) 40 of apparatus 10, in a preferred embodiment, three curved tines are provided, configured to extend radially with respect to the longitudinal axis of the outer member 12. A fewer or greater number of tines is also contemplated. Each of the tines 40 has a lumen 44, one or more openings 41 in the side wall in fluid communication with the lumen 44 of the tine, and a distal tip 42 for penetrating the vessel wall. In some embodiments, each of the tines has four side openings communicating with the tine lumen for delivering fluid to the tissue. In the embodiment where three tines 40 are provided, the tines are about 120 degrees apart. Note that a fewer or more side openings can be provided on various portions of one or more of the tines to communicate with the lumen to achieve the desired effect.


With reference to FIG. 3, in the initial position, tines 40 are positioned proximal of their respective sidewall openings 16 formed in outer tube 12 and are in a substantially straight position substantially parallel with the longitudinal axis of the needle tube 12.


Tines 40 can be composed of shape memory material, such as a nickel titanium alloy, and when in the retracted position are in a substantially straightened position within the outer member 12. When the tines 40 are deployed, the tines 40 extend through respective side openings 16 formed in the sidewall of the outer member 12 to assume a curved configuration such as that shown in FIG. 9. The tines 40 can be extended to various distances from outer member 12 and retained at such distances by a retention feature.


Note that in an alternate embodiment, stainless steel curved tines can be utilized. The stainless steel curved tines would move to a curved position when deployed.


Plunger 30 is advanced (slid) distally axially towards the housing 13, advancing the inner tube to distally to advance tines 40 through the respective side openings 16 of the outer member 12, enabling the tines 40 to extend angularly with respect to the longitudinal axis of the outer tube.


As illustrated, tines 40 remain proximal of the distal tip of outer member 12 in the deployed positions. This better controls the zone of tissue treatment. This is a result of the fact that when the tines 40 are deployed, the surgeon can be assured that the tines remain proximal of the distal edge of the catheter. However, it is also contemplated that the tines extend beyond the distal edge of the catheter.


In use, the apparatus 10 is inserted intravascularly to the target tissue site as shown in FIGS. 6-8. More specifically, the catheter is advanced over a guidewire A which is inserted through the femoral artery F and advanced intravascularly to the renal artery R such that the balloon 50 is positioned in the renal artery R adjacent to (and distally of) a branch (division) in the renal artery R. The guidewire A extends through the central lumen 29 of the catheter 12. The apparatus 10 is inserted with plunger 30 in the initial retracted position so that tines 40 are fully retracted inside outer tube 12 as shown in FIG. 1. The balloon 50 is then inflated to seal off the renal artery distally of the branch (division) as shown in FIG. 8. Plunger 30 is pushed axially inwardly to deploy the tines 40 as shown in FIG. 9, with the penetrating tips 42 penetrating the vessel wall to apply ablation fluid intravascularly, thereby ablating nerves to treat renal hypertension. As noted above, an indicator can be provided to indicate to the user that the plunger 30 has been moved from its initial position. Note, alternatively, the balloon 50 can be inflated after the plunger 30 deploys the tines 40 (but before application of ablation fluid).


Next, ablation fluid is injected through source tube 25 which flows through the inner tube and through the lumens in tines 40, exiting through holes 41 in tines 40. As shown in FIG. 9, the tines exit distal of the balloon 50. However, in the alternate embodiment of FIG. 10, the tines 40′ exit proximally of the balloon 50′ and their penetrating tips 42′ can in some embodiments remain proximal of the distal end of balloon 50′. In all other respects, tines 40′ and the apparatus of FIG. 10 are identical to tines 40 and apparatus 10 of FIG. 1. In the deployed position, tines 40 (and tines 40′) extend outwardly at an angle to the longitudinal axis, as they return to their memorized configuration.


In the alternate embodiment of FIG. 8A, catheter 112′ is identical to catheter 12 of FIG. 1 except for the provision of centering structure 113. Centering structure 113 can be in the form of a plurality of wires arranged in a basket-like structure and in the expanded position center the catheter 112 within the vessel. The centering structure can be positioned proximal of the balloon 115 as shown in FIG. 8A, or alternatively, positioned distal of the balloon 115. The centering wires are in the collapsed insertion position and when exposed from the introducer automatically move to the expanded basket-like configuration. Two or more wires can be provided to form the centering structure. The wires can be made of shape memory material. Catheter 112 is part of apparatus 110 which is otherwise identical to apparatus 10, e.g., includes a plunger, inner tube for fluid delivery, tines, etc.


Although contemplated for treating renal hypertension, it is also contemplated that the apparatus can be utilized to deliver fluid and treat other regions of the body.


While the above description contains many specifics, those specifics should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of preferred embodiments thereof. Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.

Claims
  • 1. A method for treating renal hypertension via injection of ablation fluid, the method comprising: inserting an apparatus intravascularly over a guidewire to access the renal artery, the apparatus including a flexible elongated member, an inner tube and no more than one plurality of tines received within radially spaced apart lumens defined by the elongated member that are spaced approximately equidistant from each other, the tines connected to the inner tube and having a sharp tip to penetrate a wall of the artery;placing a sealing balloon of the apparatus adjacent to a side branch in the renal artery such that an intermediate portion of the balloon spans the branch to block the branch such that a first portion of the balloon is positioned proximally of the branch and a second portion of the balloon is positioned distally of the branch, the branch branching off at an angle to a lumen of the artery;inflating the balloon to seal off the renal artery from ablation fluid distal of the branch;advancing an actuator in a first direction to deploy the plurality of tines radially through a single plurality of side openings in the elongated member located distally of the balloon so the tines penetrate the wall of the artery, the tips of the tines curving radially outwardly and each tine of the plurality of tines exit distal of the balloon such that the tips of the plurality of tines are distal of the balloon and the tips of the plurality of tines are positioned distal of the branch; andinjecting ablation fluid through a lumen in the tines and through a plurality of side openings in the tines to apply the ablation fluid and treat renal hypertension by ablating nerves;wherein the apparatus includes a centering structure positioned proximal of the balloon and the method further includes the step of expanding the centering structure, wherein the balloon blocks blood flow and the centering structure is open to enable blood flow therethrough and the side openings in the elongated member are positioned distally of the centering structure and distally of the balloon.
  • 2. The method of claim 1, wherein the tip of the tines does not extend distally of a distal tip of the apparatus.
  • 3. The method of claim 1, wherein the step of advancing the actuator is performed after the step of inflating the balloon.
  • 4. The method of claim 1, wherein the centering structure includes a basket configuration.
  • 5. The method of claim 1, wherein the actuator is actuable to a first position to move the tines from a retracted position within the elongated member of the apparatus to a deployed position extending through the side openings and radially with respect to the elongated member.
  • 6. The method of claim 1, wherein the plurality of tines are composed of shape memory metal so that advancing the actuator in a first direction exposes the tines to assume a curved shape memory position.
  • 7. The method of claim 1, wherein the centering structure is movable from a collapsed position to an expanded position.
  • 8. The method of claim 1, wherein the tines are slidable within the elongated member, and the elongated member includes a lumen dimensioned for insertion over the guidewire.
  • 9. The method of claim 8, wherein the apparatus is inserted through a femoral artery and advanced intravascularly to the renal artery.
  • 10. The method of claim 1, wherein the balloon is inflated prior to the step of injecting ablation fluid.
  • 11. The method of claim 1, wherein the lumens defined by the elongated member are arranged such that the tines are spaced approximately 120° from each other.
  • 12. The method of claim 1, wherein inflating the balloon includes communicating fluid through an inflation lumen extending axially through the flexible elongated member, the inflation lumen being located between the lumens receiving the plurality of tines.
Parent Case Info

This application is a continuation of patent application Ser. No. 14/578,366, filed Dec. 20, 2014, which claims the benefit of provisional application Ser. No. 61/940,404, filed Feb. 15, 2014. The entire contents of each of these applications are incorporated herein by reference.

US Referenced Citations (109)
Number Name Date Kind
4013080 Froning Mar 1977 A
RE31873 Howes Apr 1985 E
4645491 Evans Feb 1987 A
4760847 Vaillancourt Aug 1988 A
4769005 Ginsburg et al. Sep 1988 A
4808157 Coombs Feb 1989 A
4842585 Witt Jun 1989 A
4846799 Tanaka et al. Jul 1989 A
4869259 Elkins Sep 1989 A
4894057 Howes Jan 1990 A
4926860 Stice et al. May 1990 A
4958901 Coombs Sep 1990 A
5067957 Jervis Nov 1991 A
5102396 Bommarito Apr 1992 A
5139485 Smith et al. Aug 1992 A
5160323 Andrew Nov 1992 A
5195526 Michelson Mar 1993 A
5207652 Kay May 1993 A
5215527 Beck et al. Jun 1993 A
5231989 Middleman et al. Aug 1993 A
5236424 Imran Aug 1993 A
5242448 Pettine et al. Sep 1993 A
5275611 Behl Jan 1994 A
5354279 Hofling Oct 1994 A
5360416 Ausherman et al. Nov 1994 A
5385148 Lesh et al. Jan 1995 A
5385544 Edwards et al. Jan 1995 A
5403311 Abele et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5419777 Hofling May 1995 A
5431649 Mulier Jul 1995 A
5435805 Edwards et al. Jul 1995 A
5458597 Edwards et al. Oct 1995 A
5464395 Faxon et al. Nov 1995 A
5507802 Imran Apr 1996 A
5558673 Edwards et al. Sep 1996 A
5562683 Chan Oct 1996 A
5562687 Chan Oct 1996 A
5588960 Edwards et al. Dec 1996 A
5599345 Edwards et al. Feb 1997 A
5601572 Middleman et al. Feb 1997 A
5607389 Edwards et al. Mar 1997 A
5611778 Brinon Mar 1997 A
5620419 Lui et al. Apr 1997 A
5672174 Gough et al. Sep 1997 A
5683384 Gough et al. Nov 1997 A
5693029 Leonhardt Dec 1997 A
5713853 Clark et al. Feb 1998 A
5738650 Gregg Apr 1998 A
5795318 Wang et al. Aug 1998 A
5810804 Gough et al. Sep 1998 A
5827276 LeVeen et al. Oct 1998 A
5849011 Jones et al. Dec 1998 A
5855576 LeVeen et al. Jan 1999 A
5863290 Gough et al. Jan 1999 A
5873865 Horzewski et al. Feb 1999 A
5897531 Amirana Apr 1999 A
5951547 Gough et al. Sep 1999 A
5964796 Imran Oct 1999 A
5980517 Gough Nov 1999 A
6004295 Langer et al. Dec 1999 A
6009877 Edwards Jan 2000 A
6059780 Gough et al. May 2000 A
6074367 Hubbell Jun 2000 A
6080150 Gough Jun 2000 A
6102887 Altman Aug 2000 A
6106521 Blewett et al. Aug 2000 A
6129726 Edwards et al. Oct 2000 A
6132425 Gough Oct 2000 A
6159196 Ruiz Dec 2000 A
6179813 Ballow et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6190360 Iancea et al. Feb 2001 B1
6200274 McNeimey Mar 2001 B1
6203524 Burney et al. Mar 2001 B1
6217554 Green Apr 2001 B1
6217559 Foster Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6228049 Schroeder et al. May 2001 B1
6231591 Desai May 2001 B1
6254573 Haim et al. Jul 2001 B1
6264667 McGuckin, Jr. Jul 2001 B1
6280424 Chang et al. Aug 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6319230 Palasis et al. Nov 2001 B1
6346095 Gross et al. Feb 2002 B1
6425887 McGuckin et al. Jul 2002 B1
6428517 Hochman et al. Aug 2002 B1
6432092 Miller Aug 2002 B2
6511458 Milo et al. Jan 2003 B2
6730061 Cuschieri et al. May 2004 B1
6905480 McGuckin et al. Jun 2005 B2
6989004 Hinchliffe et al. Jan 2006 B2
7087040 McGuckin et al. Aug 2006 B2
8399443 Seward Mar 2013 B2
8465752 Seward Jun 2013 B2
9220562 Brannan Dec 2015 B2
20020143302 Hinchliffe Oct 2002 A1
20050288730 Deem Dec 2005 A1
20080255642 Zarins Oct 2008 A1
20110200171 Beetel Aug 2011 A1
20120071832 Bunch Mar 2012 A1
20120116486 Naga May 2012 A1
20120259216 Gerrans Oct 2012 A1
20130289682 Barman Oct 2013 A1
20140358079 Fischell Dec 2014 A1
20150065945 Zarins Mar 2015 A1
Foreign Referenced Citations (2)
Number Date Country
2389625 Aug 1999 CN
9846119 Oct 1998 WO
Non-Patent Literature Citations (2)
Entry
T.G. Frank, W. Xu and A. Cuschieri, “Instruments based on shape-memory allow properties for minimal access surgery, interventional radiology and flexible endoscopy”, 2000 (4 pages).
Second Department of Internal Medicine, Faulty of Medicine, University of Tokyo, Japan, Gastroenterologia Japonica (Japan) Feb. 1991, p. 47-50, “Multiple-needle insertion method in Percutaneous ethanol injection therapy for liver neoplasms”, Shiina S; Hta Y; Niwa Y; Komatsu Y; Tanaka T; Yoshiura K; Hamada E; Ohshima M; Mutoh H; Kurita M; et al.
Related Publications (1)
Number Date Country
20180093075 A1 Apr 2018 US
Provisional Applications (1)
Number Date Country
61940404 Feb 2014 US
Continuations (1)
Number Date Country
Parent 14578366 Dec 2014 US
Child 15803498 US